RECENT NEWS
06.19.08
Idera Pharmaceuticals Forms Autoimmune Disease Scientific ...
06.13.08
Idera Pharmaceuticals to Present at BIO Business Forum 2008
EVENTS
August 5-6, 2008
BMO Capital Markets Focus on Healthcare 2008 Investor Conference
New York, NY
August 12-14, 2008
Canaccord Adams' 28th Annual Global Growth Conference
Boston, MA
Idera Pharmaceuticals develops drug candidates to treat infectious diseases, autoimmune diseases, cancer, and respiratory diseases, and for use as vaccine adjuvants. Our proprietary drug candidates are designed to modulate specific Toll-like Receptors, which are a family of immune system receptors that direct immune system responses. Our pioneering DNA and RNA chemistry expertise enables us to create drug candidates for internal development and generates opportunities for multiple collaborative alliances.